ICMR approves anti-malarial drug HCQ for healthcare and frontline workers
ICMR approves anti-malarial drug HCQ for healthcare and frontline workers
In its revised advisory, IMCR has approved the use of Hydroxychloroquine (HCQ) as a preventive therapy against Coronavirus to asymptomatic health workers and asymptomatic frontline workers.